Rhythm Pharmaceuticals, Inc. (RYTM)
112.45
-0.07
(-0.06%)
USD |
NASDAQ |
Dec 16, 16:00
112.41
-0.04
(-0.04%)
After-Hours: 20:00
Rhythm Pharmaceuticals Research and Development Expense (Annual): 237.25M for Dec. 31, 2024
Research and Development Expense (Annual) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (Annual) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (Annual) Benchmarks
| Eli Lilly & Co. | 10.99B |
| Gilead Sciences, Inc. | 5.816B |
| Johnson & Johnson | 17.26B |
| Terns Pharmaceuticals, Inc. | 70.11M |
| ACADIA Pharmaceuticals, Inc. | 303.25M |